Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.43M Sell
29,058
-52,126
-64% -$6.02M 0.27% 44
2026
Q1
$9.7M Sell
81,184
-107,188
-57% -$14.1M 0.88% 22
2025
Q4
$25.7M Sell
188,372
-23,633
-11% -$3.4M 1.53% 23
2025
Q3
$31.3M Buy
212,005
+3,750
+2% +$520K 1.77% 23
2025
Q2
$24.9M Hold
208,255
1.42% 26
2025
Q1
$24.9M Buy
208,255
+58,643
+39% +$7.27M 1.42% 26
2024
Q4
$17.4M Buy
+149,612
New +$18.9M 0.94% 35
2023
Q3
Sell
-67,328
Closed -$7.58M 76
2023
Q2
$7.58M Buy
67,328
+12,979
+24% +$1.37M 0.66% 47
2023
Q1
$5.69M Buy
54,349
+3,819
+8% +$399K 0.42% 65
2022
Q4
$5.59M Buy
50,530
+23,712
+88% +$2.49M 0.47% 65
2022
Q3
$2.34M Buy
+26,818
New +$2.44M 0.19% 93
2022
Q1
Sell
-55,431
Closed -$6.65M 66
2021
Q4
$6.65M Sell
55,431
-32,281
-37% -$4.01M 0.25% 56
2021
Q3
$10.8M Sell
87,712
-19,708
-18% -$2.54M 0.43% 38
2021
Q2
$12.9M Sell
107,420
-2,412
-2% -$275K 0.5% 36
2021
Q1
$11.6M Buy
109,832
+777
+0.7% +$78.8K 0.44% 36
2020
Q4
$11.1M Buy
109,055
+472
+0.4% +$44.4K 0.47% 32
2020
Q3
$9.13M Sell
108,583
-14,178
-12% -$1.1M 0.4% 33
2020
Q2
$7.97M Buy
122,761
+18,527
+18% +$1.22M 0.4% 34
2020
Q1
$6.79M Buy
104,234
+25,450
+32% +$2.01M 0.45% 33
2019
Q4
$6.21M Buy
78,784
+4,959
+7% +$386K 0.4% 27
2019
Q3
$5.88M Buy
73,825
+47,599
+181% +$3.74M 0.43% 28
2019
Q2
$2.19M Buy
26,226
+5,203
+25% +$415K 0.17% 28
2019
Q1
$1.66M Buy
21,023
+881
+4% +$64.3K 0.15% 31
2018
Q4
$1.34M Buy
20,142
+1,400
+7% +$96.9K 0.15% 32
2018
Q3
$1.5M Buy
+18,742
New +$1.4M 0.14% 33

Other funds holding XYL

Formuepleje A/S's XYL Position: Q2 2026 in Review

Formuepleje A/S reduced its Xylem (XYL) stake by 64% in Q2 2026, selling an estimated $6.02M and leaving 29,058 shares worth $3.43M. The position accounts for 0.27% of the portfolio, ranked #44.

Formuepleje A/S first reported a position in XYL in Q3 2018 and has held it in 25 quarters since. The position peaked at $31.3M in Q3 2025. 1,096 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Formuepleje A/S held 29,058 shares of Xylem worth $3.43M as of Q2 2026.
  • Formuepleje A/S sold 52,126 Xylem shares in Q2 2026, an estimated $6.02M.
  • Xylem made up 0.27% of Formuepleje A/S's portfolio in Q2 2026, its #44 holding.
  • Formuepleje A/S first reported a position in Xylem in Q3 2018 and has held it in 25 quarters since.
  • Formuepleje A/S's Xylem position peaked at $31.3M in Q3 2025.
  • 1,096 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Formuepleje A/S's 13F filing for Q2 2026, filed 27 Aug 2026.